Systemic treatment strategies for triple-negative breast cancer

Table 1 Pathological complete response to triple-negative breast cancer in triple-negative breast cancer and non-triple-negative breast cancer patients

Ref.	Yr	No.	Therapy	PCR (%)
				TNBC	Non-TNBC
Liedtke et al[3]	2008	255	FAC → P	22	11
Chappuis et al[4]	2002	9	FEC 3 wk × 3-4	44	4
Skrypnikova et al[10]	2011	15	ACC	29.4	NR
Rouzier et al[11]	2005	82	P → FAC	45	6

FAC: 5-Fluorouracil, doxorubicin, cyclophosphamide; ACC: Doxorubicin, cyclophosphamide, capecitabine; P: Paclitaxel; PCR: Pathological complete response; TNBC: Triple-negative breast cancer; FEC: 5-Fluorouracil, epirubicin, cyclophosphamide.